Table_2_Decellularized Human Dermal Matrix as a Biological Scaffold for Cardiac Repair and Regeneration.DOCX (657.43 kB)

Table_2_Decellularized Human Dermal Matrix as a Biological Scaffold for Cardiac Repair and Regeneration.DOCX

Download (657.43 kB)
posted on 2020-03-20, 12:33 authored by Immacolata Belviso, Veronica Romano, Anna Maria Sacco, Giulia Ricci, Diana Massai, Marcella Cammarota, Angiolina Catizone, Chiara Schiraldi, Daria Nurzynska, Mara Terzini, Alessandra Aldieri, Gianpaolo Serino, Fabrizio Schonauer, Felice Sirico, Francesco D’Andrea, Stefania Montagnani, Franca Di Meglio, Clotilde Castaldo

The complex and highly organized environment in which cells reside consists primarily of the extracellular matrix (ECM) that delivers biological signals and physical stimuli to resident cells. In the native myocardium, the ECM contributes to both heart compliance and cardiomyocyte maturation and function. Thus, myocardium regeneration cannot be accomplished if cardiac ECM is not restored. We hypothesize that decellularized human skin might make an easily accessible and viable alternate biological scaffold for cardiac tissue engineering (CTE). To test our hypothesis, we decellularized specimens of both human skin and human myocardium and analyzed and compared their composition by histological methods and quantitative assays. Decellularized dermal matrix was then cut into 600-μm-thick sections and either tested by uniaxial tensile stretching to characterize its mechanical behavior or used as three-dimensional scaffold to assess its capability to support regeneration by resident cardiac progenitor cells (hCPCs) in vitro. Histological and quantitative analyses of the dermal matrix provided evidence of both effective decellularization with preserved tissue architecture and retention of ECM proteins and growth factors typical of cardiac matrix. Further, the elastic modulus of the dermal matrix resulted comparable with that reported in literature for the human myocardium and, when tested in vitro, dermal matrix resulted a comfortable and protective substrate promoting and supporting hCPC engraftment, survival and cardiomyogenic potential. Our study provides compelling evidence that dermal matrix holds promise as a fully autologous and cost-effective biological scaffold for CTE.